12:00 AM
Oct 18, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Hextend hetastarch: Marketed

A preliminary analysis of BTX's Phase IV trial of 47 patients over 60 years old undergoing major elective surgery...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >